Last reviewed · How we verify

Continuous Oxytocin

Ain Shams Maternity Hospital · FDA-approved active Small molecule

Continuous oxytocin stimulates uterine muscle contractions and promotes milk letdown by binding to oxytocin receptors on myoepithelial cells.

Continuous oxytocin stimulates uterine muscle contractions and promotes milk letdown by binding to oxytocin receptors on myoepithelial cells. Used for Labor induction, Augmentation of labor, Prevention or treatment of postpartum hemorrhage.

At a glance

Generic nameContinuous Oxytocin
Also known assyntocinon
SponsorAin Shams Maternity Hospital
Drug classOxytocin receptor agonist
TargetOxytocin receptor (OXTR)
ModalitySmall molecule
Therapeutic areaObstetrics
PhaseFDA-approved

Mechanism of action

Oxytocin is a naturally occurring peptide hormone that acts on G-protein coupled oxytocin receptors located on uterine smooth muscle and breast tissue. In obstetric settings, continuous infusion induces or augments labor by triggering rhythmic uterine contractions. It also facilitates milk ejection during lactation by contracting myoepithelial cells in mammary glands.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results